BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
6/27/2022 9:34:47 AM | Browse: 469 | Download: 1010
 |
Received |
|
2021-11-23 19:56 |
|
Peer-Review Started |
|
2021-11-23 19:57 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2022-01-12 06:22 |
|
Revised |
|
2022-01-15 15:35 |
|
Second Decision |
|
2022-06-06 03:29 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2022-06-17 22:54 |
|
Articles in Press |
|
2022-06-17 22:54 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2022-06-20 14:45 |
|
Publish the Manuscript Online |
|
2022-06-27 09:34 |
| ISSN |
1948-9366 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Letter to the Editor |
| Article Title |
Advances and effectiveness of the immunotherapy after liver transplantation
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Sai Swarupa R Vulasala, Nirmal K Onteddu, Sindhu P Kumar, Chandana Lall, Priya Bhosale and Mayur K Virarkar |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Sai Swarupa R Vulasala, MBBS, Research Assistant, Department of Radiology, University of Florida College of Medicine, 655 West 8th Street, C90, 2nd Floor, Clinical Center, Jacksonville, FL 32209, United States. vulasalaswarupa@gmail.com |
| Key Words |
Immunotherapy; Hepatocellular carcinoma; Immune checkpoint inhibitors; Liver transplantation; Solid organ transplant; Graft rejection |
| Core Tip |
There is an increased risk of cancer among transplant recipients receiving chronic immunosuppression. Immunotherapy has a beneficiary effect over immunosuppressors in reducing the overall cancer risk. However, there are very few studies that included solid organ transplant recipients while studying the efficacy of immunotherapy. “Immunotherapy after liver transplantation: Where are we now?” is a study, where the authors described the mechanism of action and outcomes of immune checkpoint inhibitors specific to liver transplant recipients. |
| Publish Date |
2022-06-27 09:34 |
| Citation |
Vulasala SSR, Onteddu NK, Kumar SP, Lall C, Bhosale P, Virarkar MK. Advances and effectiveness of the immunotherapy after liver transplantation. World J Gastrointest Surg 2022; 14(6): 629-631 |
| URL |
https://www.wjgnet.com/1948-9366/full/v14/i6/629.htm |
| DOI |
https://dx.doi.org/10.4240/wjgs.v14.i6.629 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
